Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer
about
Glycosylation of glycolipids in cancer: basis for development of novel therapeutic approachesDysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic AgentsMolecular recognition of gangliosides and their potential for cancer immunotherapiesAssociation of Nuclear PIM1 Expression with Lymph Node Metastasis and Poor Prognosis in Patients with Lung Adenocarcinoma and Squamous Cell CarcinomaGanglioside GM3 Is Antiangiogenic in Malignant Brain CancerMALDI imaging mass spectrometry profiling of N-glycans in formalin-fixed paraffin embedded clinical tissue blocks and tissue microarraysThe dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical dataThe number and microlocalization of tumor-associated immune cells are associated with patient's survival time in non-small cell lung cancerNGcGM3 ganglioside: a privileged target for cancer vaccinesSclerotium rolfsii lectin induces stronger inhibition of proliferation in human breast cancer cells than normal human mammary epithelial cells by induction of cell apoptosis.Detection of N-glycolyl GM3 ganglioside in neuroectodermal tumors by immunohistochemistry: an attractive vaccine target for aggressive pediatric cancer.Tissue Reactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Tumors of Neuroectodermal, Mesodermal, and Epithelial Origin.Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms.Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences.Anti-idiotype antibodies in cancer treatment: the pharmaceutical industry perspective.Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer.Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3.Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis.Frequent co-expression of EGFR and NeuGcGM3 ganglioside in cancer: it's potential therapeutic implications.Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis.Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer.Cross-talk between tumor and myeloid cells: how to tip the balance in favor of antitumor immunity.Maintenance treatment with chemotherapy and immunotherapy in non-small cell lung cancer: a case report.Pilot study of a novel combination of two therapeutic vaccines in advanced non-small-cell lung cancer patients.Actual status of therapeutic vaccination in non-small cell lung cancerImmunotherapy: is a minor god yet in the pantheon of treatments for lung cancer?Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysisExtracellular Proton Concentrations Impacts LN229 Glioblastoma Tumor Cell Fate via Differential Modulation of Surface Lipids.Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung Cancer.Racotumomab for treating lung cancer and pediatric refractory malignancies.Anti-NeuGcGM3 reactivity: a possible role of natural antibodies and B-1 cells in tumor immunosurveillance.A shift from N-glycolyl- to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells.Human antibodies reactive to NeuGcGM3 ganglioside have cytotoxic antitumor properties.Detection of N-glycolyated gangliosides in non-small-cell lung cancer using GMR8 monoclonal antibody.N-Glycolyl GM3 ganglioside immunoexpression in oral mucosal melanomas of Chinese.Correlation of activated STAT3 expression with clinicopathologic features in lung adenocarcinoma and squamous cell carcinoma.Activated STAT3 correlates with prognosis of non-small cell lung cancer and indicates new anticancer strategies.Immunoreactivity of the 14F7 Mab (Raised against N-Glycolyl GM3 Ganglioside) as a Positive Prognostic Factor in Non-Small-Cell Lung Cancer.EGFR and KRAS mutations do not enrich for the activation of IL-6, JAK1 or phosphorylated STAT3 in resected lung adenocarcinoma.
P2860
Q21129299-922B6F43-6BF4-4449-8859-46F04B8DB41EQ26771367-46AC748A-6E17-4F33-A83B-814BF8340D8FQ26830588-D740236F-FA21-460F-9990-A83843C965E7Q27853352-50C159AD-6A7C-4442-A973-361080DB6167Q28397085-A6C422F1-45CB-469B-AAC2-D86B26F67761Q28542741-51E02B9B-DBB1-46F9-BD19-A19B8D29477DQ30317628-C2B10C83-C131-41C9-9DA2-04A60292FEE2Q30575331-4BDBAC92-F222-4071-AEBF-1E2D6849D193Q33582755-9E740845-0BCF-4F25-A410-22B08F9B0249Q34247856-67AF0373-BD4B-467E-A49C-4F7158B1B535Q34443740-F682DC94-8B8F-4FE2-8A9E-DEE3ED05E380Q35224101-AAAAF4F3-8881-43DD-B280-781233F49E65Q35623519-56403440-41FA-45E3-80CB-98E1A1FE71D0Q35684309-3D3BD981-A563-4DA6-B3A0-E770358DBAE5Q36304631-33CFFAAA-85ED-40F2-BA2A-9FAF1A9925F4Q36352693-378666BF-330A-4A13-8860-D1CB71909A9CQ36382557-BDA74470-FCEB-4CF2-8950-528A1AD38A0CQ36540352-1B092F91-E412-49F0-B233-839267855E29Q37190200-19350637-AA64-430E-ACE4-CE8D5C4F58FFQ37280403-133DDBB2-6677-491C-A2FC-2C0BABCCEF8AQ37393097-34C7969C-50EB-4B8D-8635-69CB834D9ECBQ37594945-D4F22F0C-7DCB-4492-A12F-27E30F53C499Q37822746-78BB8B10-4697-4D17-8593-91FD0EADEE86Q38056730-5C7FBA28-38C0-493E-BE9E-DBA433E0FCCEQ38207923-A2F0F612-5450-4A07-8563-E97307CBE60DQ38223388-B8DB3ECE-3817-4117-8616-7FE9696E2811Q38242271-9734E80F-75D6-4C82-AC23-BDC316160DE2Q38630276-A609F776-863E-49FC-8710-9061F4E0F6ACQ38712123-D9EFF968-0C60-4DF2-9A43-BF8B50ED6C77Q38726208-33F193F4-A258-4ECF-B5DE-CB7FE665DEB1Q38745411-C3F23DA7-9B06-4EC8-99BD-9F0B2714A543Q38848896-3D793E29-93D2-435B-BB1B-7DFEDD6DEE38Q39172701-EFE9A517-1327-436F-9DE1-F6B4506FD2E0Q39210534-013922F8-98E5-4F6D-BB9F-209FE0ACFC74Q39273021-D06B80F1-CB98-4C59-829B-9EBF1F5261F1Q39350862-0A3A30DB-19E4-441D-A184-E8F2BDCCD470Q39669033-407EB78D-AE60-4E37-89BE-D1FD60EA0015Q41310543-2C8A7487-4173-41E1-A793-3F1DFAFBE2FFQ42560665-6562C41D-2398-41B5-B4B9-D573AB795AEBQ47780922-9D8CF20E-C399-443E-942A-67D4535935D4
P2860
Tissue micro array analysis of ganglioside N-glycolyl GM3 expression and signal transducer and activator of transcription (STAT)-3 activation in relation to dendritic cell infiltration and microvessel density in non-small cell lung cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Tissue micro array analysis of ...... in non-small cell lung cancer
@ast
Tissue micro array analysis of ...... in non-small cell lung cancer
@en
type
label
Tissue micro array analysis of ...... in non-small cell lung cancer
@ast
Tissue micro array analysis of ...... in non-small cell lung cancer
@en
prefLabel
Tissue micro array analysis of ...... in non-small cell lung cancer
@ast
Tissue micro array analysis of ...... in non-small cell lung cancer
@en
P2093
P2860
P356
P1433
P1476
Tissue micro array analysis of ...... in non-small cell lung cancer
@en
P2093
Hester van Cruijsen
Mariëlle Gallegos Ruiz
Paul van der Valk
Tanja D de Gruijl
P2860
P2888
P356
10.1186/1471-2407-9-180
P407
P577
2009-06-11T00:00:00Z
P5875
P6179
1043040268